In another study, the analysis of EVsfrom the plasma of BC donors identified 10 candidate biomarkers, whose levelswere higher in BC patients than in healthy subjects (CD3, CD56, CD2, CD25, CD9,CD44, CD326, CD133/1, CD142, and CD14). The gene discussed is CD2; the disease is breast cancer.